We use cookies to help us improve your browsing experience and understand how people use our website. Our privacy statement explains how we use cookies, and how to change your cookie settings.
Annual report 2018

New milestone for Galapagos

Data FINCH 1 & 3 studies with filgotinib disclosed
We published our Annual Report 2018

Read press releases
Read Onno’s message
Watch ‘Think Big’ video
Read Annual Report

We are Galapagos

Galapagos is a clinical-stage biotechnology company, specialized in the discovery and development of small molecule medicines with novel modes of action. Our ambition is to become a leading global biopharmaceutical company, focused on the discovery, development and commercialization of innovative medicines that will improve people's lives. 

Learn more about Galapagos



All Galapagos news



All Galapagos events

Current Openings


All Current Openings